Tirzepatide (Zepbound/Mounjaro) at 15mg produces 20.9% over 72 weeks
Bring printed or digital copies of recent clinical trial summaries or your lab results showing metabolic markers
In fact, the omitted study was a pooled analysis of 5 RCTs 196,197,198,199,200 of 5,325 patients with obesity followed for up to 3 years, which had shown that liraglutide was no different from placebo for depressive symptoms as scored on the Patient Health Questionnaire-9, while also highlighting a small increased risk of suicidal behavior 193
Pfizers lotiglipron was scrapped in June 2023 over transaminase elevations in Phase I studies
There are several interventions capable of promoting adherence to pharmacological treatment
This means the Feds actions, and statements, will be more closely watched than ever